MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+1.86%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$463M
AUM Growth
+$463M
(+7.2%)
Cap. Flow
+$56.9M
Cap. Flow
% of AUM
12.3%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Entrada Therapeutics
TRDA
|
$75.8M |
Top Sells
| 1 |
iTeos Therapeutics
ITOS
|
$18.9M |
| 2 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$22 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iTeos Therapeutics
ITOS
| $134M | 29.03% | 2,885,470 -405,241 | -12% | -$18.9M |
|
|
2
Entrada Therapeutics
TRDA
$208M
| $75.8M | 16.37% | +4,425,784 | New | +$75.8M |
|
3
Dyne Therapeutics
DYN
$1.92B
| $58.9M | 12.72% | 4,951,303 | – | – |
|
4
Werewolf Therapeutics
HOWL
$59.9M
| $51M | 11.03% | 4,284,172 | – | – |
|
5
Repare Therapeutics
RPTX
$71.7M
| $47.3M | 10.22% | 2,242,636 | – | – |
|
|
AMYT
6
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $28.8M | 6.23% | 2,668,843 -2 | -0% | -$22 |
|
|
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $23.6M | 5.11% | 3,131,388 | – | – |
|
|
TCRR
8
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $18.9M | 4.08% | 4,050,865 | – | – |
|
|
ONCR
9
DELISTED
Oncorus, Inc.
ONCR
| $15M | 3.25% | 2,849,464 | – | – |
|
10
Rhythm Pharmaceuticals
RYTM
$6.85B
| $9.07M | 1.96% | 909,258 | – | – |
|